J. R. Arron, M. M. Winslow, A. Polleri, C. P. Chang, H. Wu et al., NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21, Nature, vol.441, pp.595-600, 2006.

I. Bardou, H. M. Brothers, R. M. Kaercher, S. C. Hopp, and G. L. Wenk, Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus, Neurobiol Aging, vol.34, pp.2293-2301, 2013.

C. Branca, D. M. Shaw, R. Belfiore, V. Gokhale, A. Y. Shaw et al., Dyrk1 inhibition improves Alzheimer's disease-like pathology, Aging Cell: Doi, 2017.

L. C. Bui, L. Tabouy, F. Busi, J. M. Dupret, J. N. Planque et al., A high-performance liquid chromatography assay for Dyrk1a, a Down syndrome-associated kinase, Anal Biochem, vol.449, pp.172-178, 2014.

J. E. Burda and M. V. Sofroniew, Reactive gliosis and the multicellular response to CNS damage and disease, Neuron, vol.81, pp.229-248, 2014.

E. Chen, D. Xu, X. Lan, B. Jia, L. Sun et al., A novel role of the STAT3 pathway in brain inflammation-induced human neural progenitor cell differentiation, Curr Mol Med, vol.13, pp.1474-1484, 2013.

T. Chiba, M. Yamada, J. Sasabe, K. Terashita, M. Shimoda et al., Amyloid-beta causes memory impairment by disturbing the JAK2/ STAT3 axis in hippocampal neurons, Mol Psychiatry, vol.14, pp.206-222, 2009.

M. Debdab, F. Carreaux, R. S. Soundararajan, M. Fedorov, O. Filippakopoulos et al., Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing, J med Chem, vol.54, pp.4172-4186, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00870007

J. M. Delabar, D. Theophile, Z. Rahmani, Z. Chettouh, J. L. Blouin et al., Molecular mapping of twenty-four features of Down syndrome on chromosome 21, Eur J Hum Genet, vol.1, pp.114-124, 1993.

D. Filippo, M. Sarchielli, P. Picconi, B. Calabresi, and P. , Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders, Trends Pharmacol Sci, vol.29, pp.402-412, 2008.

I. Ferrer, M. Barrachina, B. Puig, M. Martinez-de-lagran, M. E. Avila et al., Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, pick disease, and related transgenic models, Neurobiol Dis, vol.20, pp.392-400, 2005.

R. Fol, J. Braudeau, S. Ludewig, T. Abel, S. W. Weyer et al., Viral gene transfer of APPsalpha rescues synaptic failure in an Alzheimer's disease mouse model, Acta Neuropathol, 2015.

N. Gockler, G. Jofre, C. Papadopoulos, U. Soppa, F. J. Tejedor et al., Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation, FEBS J, vol.276, pp.6324-6337, 2009.

R. Guerreiro, A. Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva et al., TREM2 variants in Alzheimer's disease, N Engl J med, vol.368, pp.117-127, 2013.

J. Hardy and D. J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, vol.297, pp.353-356, 2002.

J. V. Haure-mirande, M. Audrain, T. Fanutza, S. H. Kim, W. L. Klein et al., Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology, Acta Neuropathol, 2017.

E. Head, I. T. Lott, D. M. Wilcock, and C. A. Lemere, Aging in Down syndrome and the development of Alzheimer's disease neuropathology, Curr Alzheimer Res, vol.13, pp.18-29, 2016.

M. H. Heim, The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus, J Recept Signal Transduct Res, vol.19, pp.75-120, 1999.

M. T. Heneka, M. J. Carson, E. Khoury, J. Landreth, G. E. Brosseron et al., Neuroinflammation in Alzheimer's disease, Lancet Neurol, vol.14, pp.388-405, 2015.

S. E. Hickman, E. K. Allison, E. Khoury, and J. , Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice, J Neurosci, vol.28, p.8354, 2008.

C. Holmes, C. Cunningham, E. Zotova, J. Woolford, C. Dean et al., Systemic inflammation and disease progression in Alzheimer disease, Neurology, vol.73, pp.768-774, 2009.

J. L. Jankowsky, D. J. Fadale, J. Anderson, G. M. Xu, V. Gonzales et al., Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase, Hum Mol Genet, vol.13, pp.159-170, 2004.

N. Jin, X. Yin, J. Gu, X. Zhang, J. Shi et al., Truncation and activation of dual specificity tyrosine phosphorylation-regulated kinase 1A by Calpain I: a MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE, J Biol Chem, vol.290, pp.15219-15237, 2015.

H. Kentrup, W. Becker, J. Heukelbach, A. Wilmes, A. Schurmann et al., Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII, J Biol Chem, vol.271, pp.3488-3495, 1996.

V. Kohli, W. Gao, C. A. Camargo, J. Clavien, and P. A. , Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation, Proc Natl Acad Sci U S A, vol.94, pp.9354-9359, 1997.

N. Kurabayashi, M. D. Nguyen, and K. Sanada, DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model, EMBO rep, vol.16, pp.1548-1562, 2015.

M. S. Lee, Y. T. Kwon, M. Li, J. Peng, R. M. Friedlander et al., Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, vol.405, pp.360-364, 2000.

S. A. Liddelow, K. A. Guttenplan, L. E. Clarke, F. C. Bennett, C. J. Bohlen et al., Neurotoxic reactive astrocytes are induced by activated microglia, Nature, vol.541, pp.481-487, 2017.

F. Liu, Z. Liang, J. Wegiel, Y. W. Hwang, K. Iqbal et al., Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome, FASEB J, vol.22, pp.7-104539, 2008.

R. Medeiros, M. Kitazawa, M. A. Chabrier, D. Cheng, D. Baglietto-vargas et al., Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice, Am J Pathol, vol.181, pp.616-625, 2012.

T. L. Nguyen, C. Fruit, Y. Herault, L. Meijer, and T. Besson, Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature, Expert Opin Ther Pat, vol.27, pp.1183-1199, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02046302

M. Rechsteiner and S. W. Rogers, PEST sequences and regulation by proteolysis, Trends Biochem Sci, vol.21, pp.267-271, 1996.

P. Rudrabhatla, H. Jaffe, and H. C. Pant, Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs, FASEB J, vol.25, pp.3896-3905, 2011.

S. R. Ryoo, H. J. Cho, H. W. Lee, H. K. Jeong, C. Radnaabazar et al., Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease, J Neurochem, vol.104, pp.1333-1344, 2008.

S. R. Ryoo, H. K. Jeong, C. Radnaabazar, J. J. Yoo, H. J. Cho et al., DYRK1A-mediated hyperphosphorylation of tau. A functional link between Down syndrome and Alzheimer disease, J Biol Chem, vol.282, pp.34850-34857, 2007.

Y. S. Ryu, S. Y. Park, M. S. Jung, S. H. Yoon, M. Y. Kwen et al., Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease, J Neurochem, vol.115, pp.574-584, 2010.

M. Serpente, R. Bonsi, E. Scarpini, and D. Galimberti, Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment, Neuroimmunomodulation, vol.21, pp.79-87, 2014.

A. R. Simard, D. Soulet, G. Gowing, J. P. Julien, and S. Rivest, Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease, Neuron, vol.49, pp.489-502, 2006.

B. Smith, F. Medda, V. Gokhale, T. Dunckley, and C. Hulme, Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?, ACS Chem Neurosci, vol.3, pp.857-872, 2012.

M. V. Sofroniew, Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators, Neuroscientist, vol.20, pp.160-172, 2014.

T. Tahtouh, J. M. Elkins, P. Filippakopoulos, M. Soundararajan, G. Burgy et al., Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B, J med Chem, vol.55, pp.9312-9330, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00870472

E. Tarkowski, N. Andreasen, A. Tarkowski, and K. Blennow, Intrathecal inflammation precedes development of Alzheimer's disease, J Neurol Neurosurg Psychiatry, vol.74, pp.1200-1205, 2003.

F. Trinchese, M. Fa, S. Liu, H. Zhang, A. Hidalgo et al., Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease, J Clin Invest, vol.118, pp.2796-2807, 2008.

J. A. Ubersax and J. E. Ferrell, Mechanisms of specificity in protein phosphorylation, Nat Rev Mol Cell Biol, vol.8, pp.530-541, 2007.

J. Wan, A. K. Fu, F. C. Ip, H. K. Ng, J. Hugon et al., Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease, J Neurosci, vol.30, pp.6873-6881, 2010.

Y. L. Woods, P. Cohen, W. Becker, R. Jakes, M. Goedert et al., The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase, Biochem J, vol.355, pp.609-615, 2001.

T. Yoon, J. Okada, M. W. Jung, and J. J. Kim, Prefrontal cortex and hippocampus subserve different components of working memory in rats, Learn Mem, vol.15, pp.97-105, 2008.

Y. Zhao, X. Wu, X. Li, L. L. Jiang, X. Gui et al., TREM2 is a receptor for beta-amyloid that mediates microglial function, Zhang Met al, vol.97, pp.1023-1031, 2018.

Y. Zou, S. Lim, K. Lee, X. Deng, and E. Friedman, Serine/threonine kinase mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the met adaptor ran-binding protein M, J Biol Chem, vol.278, pp.49573-49581, 2003.